RPG Life Sciences' (NSE:RPGLIFE, BOM:532983) profit surged to 1.17 billion Indian rupees in the fiscal fourth quarter ended March 31 against 132.4 million rupees a year ago.
Earnings per share climbed to 70.96 rupees compared with the year-ago figure of 8.01 rupees, according to a Monday filing to the Indian stock exchanges by the pharmaceuticals manufacturer.
Revenue from operations in fiscal Q4 increased to 1.43 billion rupees from 1.27 billion rupees a year earlier.
The board of directors recommended a final dividend of 20 rupees per equity share of the face value of 8 rupees each for the fiscal year ended March 31.
A special dividend of 4 rupees per equity share of face value of 8 rupees each has also been recommended on account of significant exceptional profit on the assignment of land.
The company's shares were up nearly 3% in recent trade.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.